Fascin and CK4 as biomarkers for esophageal squamous cell carcinoma

Anticancer Research

Volumn 31, Issue 3, 2011, Pages 945-952

  Takikita, Mikiko ^a   Hu, Nan ^a   Shou, Jian Zhong ^b   Giffen, Carol ^c   Wang, Quan Hong ^d   Wang, Chaoyu ^a   Hewitt, Stephen M ^a   Taylor, Philip R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CANCER HOSPITAL   (China)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

^d SHANXI CANCER HOSPITAL   (China)

Author keywords

Biomarker; Cytokeratin 4; Esophagus; Fascin; Squamous cell carcinoma; Tissue microarray

Indexed keywords

CYTOKERATIN 14; CYTOKERATIN 4; FASCIN; OSTEONECTIN;

ADULT; ARTICLE; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; DISEASE ASSOCIATION; DYSPLASIA; EPITHELIUM; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; TISSUE MICROARRAY;

BIOPSY; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-4; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; ODDS RATIO; REGRESSION ANALYSIS; RISK FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79956083926     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. The Global Burden of Disease: 2004 update. Geneva: World Healrh Organization, 2008. (http://www.who.int/healthinfo/global-burden-disease/GBD- report-2004update-full.pdf.).
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 4: 225-249, 2008.
3. Brown L and Devesa S: Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 11: 235-256, 2002. (Pubitemid 34951272)
4. Devesa SS, Blot WJ and Fraumeni JF Jr.: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83: 2049-2053, 1998. (Pubitemid 28525384)
5. El-Serag H, Mason A, Petersen N and Key C: Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 50: 368-372, 2002.
6. Pohl H and Welch H: The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97: 142-146, 2005. (Pubitemid 40277094)
7. Li J: Epidemiology of esophageal cancer in China. Natl Cancer Inst Monogr 62: 113-120, 1982.
8. Hu, N, Qian L, Hu Y, Shou JZ, Wang C, Giffen C, Wang QH, Wang Y, Goldstein AM, Emmert Buck M and Taylor PR: Quantitative real time RT PCR validation of differential mRNA expression of SPARC, FADD, Fascin, COL7A1, CK4, TGM3, ECM1, PPL, and EVPL in esophageal squamous cell carcinoma. BMC Cancer 6: 33, 2006.
9. Xue LY, Hu N, Song YM, Zou SM, Shou JZ, Qian LX, Ren LQ, Lin DM, Tong T, He ZG, Zhan QM, Taylor PR and Lu N: Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma. BMC Cancer 6: 296, 2006.
10. Hashimoto Y, Ito T, Inoue H, Okumura T, Tanaka E, Tsunoda S, Higashiyama M, Watanabe G, Imamura M and Shimada Y: Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin Ca Res 11: 2597-2605, 2005.
11. Su H, Hu N, Shih J, Hu Y, Wang QH, Chuang EY, Roth MJ, Wang C, Goldstein AM, Ding T, Dawsey SM, Giffen C, Emmert-Buck MR and Taylor PR: Gene expression analysis of esophageal squamous cell carcinoma reveals consistent molecular profiles related to a family history of upper gastrointestinal cancer. Cancer Res 63: 3872-3876, 2003. (Pubitemid 36917896)
12. Singh A, Kapur S, Chattopadhyay I, Purkayastha J, Sharma J, Mishra A, Hewitt SM and Saxena S: Cytokeratin immunoexpression in esophageal squamous cell carcinoma of a high-risk population in Northeast India. Appl Immunohistochem Mol Morphol 17: 419-424, 2009.
13. Shou JZ, Hu N, Takikita M, Roth MJ, Johnson LL, Giffen C, Wang QH, Wang C, Wang Y, Su H, Kong LH, Emmert-Buck MR, Goldstein AM, Hewitt SM and Taylor PR: Overexpression of CDC25B and LAMC2 mRNA and protein in esophageal squamous cell carcinomas and premalignant lesions in subjects from a high-risk population in China. Cancer Epidemiol Biomarkers Prev 17: 1424-1435, 2008.
14. Tilney L, Tilney M and Guild G: F-Actin bundles in Drosophila bristles. I. Two filament cross-links are involved in bundling. J Cell Biol 130: 629-638, 1995.
15. Kureishy N, Sapountzi V, Prag S, Anilkumar N and Adams J: Fascins, and their roles in cell structure and function. Bioessays 24: 350-361, 2002. (Pubitemid 34305690)
16. Jawhari AU, Buda A, Jenkins M, Shehzad K, Sarraf C, Noda M, Farthing MJ, Pignatelli M and Adams JC: Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol 162: 69-80, 2003. (Pubitemid 36041990)
17. Grothey A, Hashizume R, Sahin A and McCrea P: Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br J Cancer 83: 870-873, 2000.
18. Pelosi G, Pastorino U, Pasini F, Maissoneuve P, Fraggetta F, Iannucci A, Sonzogni A, De Manzoni G, Terzi A, Durante E, Bresaola E, Pezzella F and Viale G: Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer 88: 537-547, 2003. (Pubitemid 36363363)
19. Karasavvidou F, Barbanis S, Pappa D, Moutzouris G, Tzortzis V, Melekos MD and Koukoulis G: Fascin determination in urothelial carcinomas of the urinary bladder: a marker of invasiveness. Arch Pathol Lab Med 132: 1912-1915, 2008.
20. Hashimoto Y, Shimada Y, Kawamura J, Yamasaki S and Imamura M: The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 67: 262-270, 2004. (Pubitemid 39551711)
21. Moll R, Divo M and Langbein L: The human keratins: biology and pathology. Histochem Cell Biol 129: 705-733, 2008.
22. Bradshaw AD and Sage EH: SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107: 1049-1054, 2001.
23. Framson P and Sage E: SPARC and tumor growth: Where the seed meets the soil? J Cell Biochem 92: 679-690, 2004.
24. 2+-relevant and differentiation-associated genes down-regulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 23: 1291-1299, 2004. (Pubitemid 38297184)
25. Xu SH, Qian LJ, Mou HZ, Zhu CH, Zhou XM, Liu XL, Chen Y and Bao WY: Difference of gene expression profiles between esophageal carcinoma and its pericancerous epithelium by gene chip. World J Gastroenterol 9: 417-422, 2003. (Pubitemid 36372098)
26. Yamashita K, Upadhay S, Mimori K, Inoue H and Mori M: Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression. Cancer 97: 2412-2419, 2003. (Pubitemid 36542479)
27. Porte H, Triboulet JP, Kotelevets L, Carrat F, Prévot S, Nordlinger B, DiGioia Y, Wurtz A, Comoglio P, Gespach C and Chastre E: Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis. Clin Cancer Res 4: 1375-1382, 1998.
28. Xie JJ, Xu LY, Zhang HH, Cai WJ, Mai RQ, Xie YM, Yang ZM, Niu YD, Shen ZY and Li EM: Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells. Biochem Biophys Res Commun 337: 355-362, 2005. (Pubitemid 41393802)
29. Chung JY, Braunschweig T, Hu N, Roth M, Traicoff JL, Wang QH, Knezevic V, Taylor PR and Hewitt SM: A multiplex tissue immunoblotting assay for proteomic profiling: a pilot study of the normal to tumor transition of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 15: 1403-1408, 2006. (Pubitemid 44125301)
30. Viaene A and Baert J: Expression of cytokeratin-mRNAs in squamous-cell carcinoma and balloon-cell formation of human oesophageal epithelium. Histochem J 27: 69-78, 1995.
31. Kan T, Yamasaki S, Kondo K, Teratani N, Kawabe A, Kaganoi J, Meltzer SJ, Imamura M and Shimada Y: A new specific gene expression in squamous cell carcinoma of the esophagus detected using representational difference analysis and cDNA microarray. Oncology 70: 25-33, 2006.
32. Hewitt SM, Takikita M, Braunschweig T and Chung JY: Promises and challenges of predictive tissue biomarkers. Biomark Med 1: 313-318, 2007.
33. Che Y, Luo A, Wang H, Qi J, Guo J and Liu Z: The differential expression of SPARC in esophageal squamous cell carcinoma. Int J Mol Med 17: 1027-1033, 2006.